THE COMPARATIVE EFFECTIVENESS OF CYCLING TUMOURNECROSIS FACTOR INHIBITOR (TNFI) VERSUS SWAPPING TO A NONTNFI ON PATIENT-REPORTED FUNCTIONAL ABILITY OF PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Lopez-Oliva, M. A. [1 ]
Matusevich, A. [1 ]
Cantor, S. B. [2 ]
Pratt, G. [3 ]
Suarez-Almazor, M. E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Gen Internal Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Hlth Serv Res, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Res Med Lib, Houston, TX 77030 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.6989
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0298
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
  • [31] Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
    Vibeke Strand
    Laure Gossec
    Clare W. J. Proudfoot
    Chieh-I Chen
    Matthew Reaney
    Sophie Guillonneau
    Toshio Kimura
    Janet van Adelsberg
    Yong Lin
    Erin K. Mangan
    Hubert van Hoogstraten
    Gerd R. Burmester
    Arthritis Research & Therapy, 20
  • [32] Impact of patient-reported flares on radiographic progression and functional impairment in patients with rheumatoid arthritis: a cohort study based on the AMBRA trial
    Kuettel, D.
    Primdahl, J.
    Christensen, R.
    Ornbjerg, L. M.
    Horslev-Petersen, K.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (02) : 87 - 94
  • [33] PATIENT-REPORTED OUTCOMES WITH SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS ARE SIMILAR REGARDLESS OF PRIMARY OR SECONDARY FAILURE WITH TUMOUR NECROSIS FACTOR INHIBITORS
    Strand, V.
    Boklage, S.
    Mangan, E.
    Reaney, M.
    Iglesias-Rodriguez, M.
    Kimura, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 615 - 616
  • [34] Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication reply
    Sugawara, Eri
    Matsui, Kazuo
    Amasaki, Yoshiharu
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (04) : 438 - 438
  • [35] Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy
    Keystone, E.
    Burmester, G. R.
    Furie, R.
    Loveless, J. E.
    Emery, P.
    Kremer, J.
    Tak, P. P.
    Broder, M. S.
    Yu, E.
    Cravets, M.
    Magrini, F.
    Jost, F.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (06): : 785 - 793
  • [36] Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach
    Hye-Lin Kim
    Min-Young Lee
    Sun-Young Park
    Sun-Kyeong Park
    Ji-Hye Byun
    Sunhong Kwon
    Eui-Kyung Lee
    Archives of Pharmacal Research, 2014, 37 : 662 - 670
  • [37] Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach
    Kim, Hye-Lin
    Lee, Min-Young
    Park, Sun-Young
    Park, Sun-Kyeong
    Byun, Ji-Hye
    Kwon, Sunhong
    Lee, Eui-Kyung
    ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (05) : 662 - 670
  • [38] PATIENT-REPORTED OUTCOMES FROM A PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITORS
    Smolen, J. S.
    Kremer, J.
    Gaich, C.
    DeLozier, A. M.
    Schlichting, D.
    Xie, L.
    Genovese, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 785 - 786
  • [39] Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial
    Gladman, D. D.
    Mease, P. J.
    Cifaldi, M. A.
    Perdok, R. J.
    Sasso, E.
    Medich, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) : 163 - 168
  • [40] Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
    Alten, Rieke
    Burmester, Gerd R.
    Matucci-Cerinic, Marco
    Salmon, Jean-Hugues
    Ostor, Andrew
    Ng, Khai Jing
    Gerwien, Jens
    Zaremba-Pechmann, Liliana
    Brnabic, Alan J. M.
    Fautrel, Bruno
    RHEUMATOLOGY AND THERAPY, 2023, 10 (06) : 1575 - 1595
12345